浙江医学
浙江醫學
절강의학
ZHEJIANG MEDICAL JOURNAL
2014年
4期
255-258
,共4页
王小红%周星明%江洪%张谷%苏丹
王小紅%週星明%江洪%張穀%囌丹
왕소홍%주성명%강홍%장곡%소단
肺肿瘤%Stathmin
肺腫瘤%Stathmin
폐종류%Stathmin
Lung cancer%Stathmin
目的:探讨Ⅱ期非小细胞肺癌(NSCLC)中Stathmin mRNA和蛋白表达水平与患者预后的关系。方法单基因定量法检测已手术Ⅱ期NSCLC患者肿瘤组织中Stathmin mRNA表达;免疫组化法检测患者肿瘤组织中Stathmin蛋白表达水平。所有患者行长春瑞滨联合顺铂方案化疗,统计学分析其表达水平与患者临床病理学特征之间的关系,并随访患者的无瘤生存时间(DFS)和总体生存时间(OS),统计学分析StathminmRNA和蛋白表达水平与患者的DFS、OS的关系。结果 Stathmin mRNA表达水平与患者的T、N分期显著相关,与患者的年龄,病理类型均无显著相关性;Stathmin蛋白表达水平与患者的年龄、病理类型、T、N分期均无显著相关性;Stathmin mRNA和蛋白表达水平与患者的OS,DFS均无显著相关性。结论Ⅱ期NSCLC患者肿瘤组织中Stathmin表达水平不能作为预测患者预后的指标。
目的:探討Ⅱ期非小細胞肺癌(NSCLC)中Stathmin mRNA和蛋白錶達水平與患者預後的關繫。方法單基因定量法檢測已手術Ⅱ期NSCLC患者腫瘤組織中Stathmin mRNA錶達;免疫組化法檢測患者腫瘤組織中Stathmin蛋白錶達水平。所有患者行長春瑞濱聯閤順鉑方案化療,統計學分析其錶達水平與患者臨床病理學特徵之間的關繫,併隨訪患者的無瘤生存時間(DFS)和總體生存時間(OS),統計學分析StathminmRNA和蛋白錶達水平與患者的DFS、OS的關繫。結果 Stathmin mRNA錶達水平與患者的T、N分期顯著相關,與患者的年齡,病理類型均無顯著相關性;Stathmin蛋白錶達水平與患者的年齡、病理類型、T、N分期均無顯著相關性;Stathmin mRNA和蛋白錶達水平與患者的OS,DFS均無顯著相關性。結論Ⅱ期NSCLC患者腫瘤組織中Stathmin錶達水平不能作為預測患者預後的指標。
목적:탐토Ⅱ기비소세포폐암(NSCLC)중Stathmin mRNA화단백표체수평여환자예후적관계。방법단기인정량법검측이수술Ⅱ기NSCLC환자종류조직중Stathmin mRNA표체;면역조화법검측환자종류조직중Stathmin단백표체수평。소유환자행장춘서빈연합순박방안화료,통계학분석기표체수평여환자림상병이학특정지간적관계,병수방환자적무류생존시간(DFS)화총체생존시간(OS),통계학분석StathminmRNA화단백표체수평여환자적DFS、OS적관계。결과 Stathmin mRNA표체수평여환자적T、N분기현저상관,여환자적년령,병리류형균무현저상관성;Stathmin단백표체수평여환자적년령、병리류형、T、N분기균무현저상관성;Stathmin mRNA화단백표체수평여환자적OS,DFS균무현저상관성。결론Ⅱ기NSCLC환자종류조직중Stathmin표체수평불능작위예측환자예후적지표。
Objective To investigate the expression of Stathmin in stageⅡ non- smal celllung cancer (NSCLC) and its significance. Methods The expression of Stathmin mRNA and protein was detected by Quanti- Gene Assay and immunohisto-chemistry, respectively. Al patients received NP chemotherapy. The patients were fol owed- up;the disease- free survival (DFS) and overal survival (OS) were observed. The correlation of Stathmin expression level with the clinicopathological features of NSCLC and prognosis of patients were analyzed. Results Stathmin mRNA expression levels was significantly correlated with T stage and N stage. There was no significant correlation of Stathmin mRNA and protein expression levels with the OS and DFS of patients. Conclusion In patients with stage Ⅱ NSCLC, the expression levels of Stathmin mRNA and protein in cancer tissue cannot be used as a prognostic indicator.